0371 384 2030 Enquire

Spire Healthcare welcomes two new non-executive director appointments

06 Mar 2025

Spire Healthcare, the leading independent healthcare group in the UK, has added wide-ranging experience to its Board of Directors, welcoming two new members who hold extensive senior-level healthcare management expertise.

Spire is pleased to announce the following Non-Executive Director appointments effective as of today:

Sir David Sloman will join as a non-independent Non-Executive Director. Sir David will become a member of the Company’s Clinical Governance and Safety Committee on appointment and will replace Dame Janet as chair on 14 May 2025. He will also take on the role of Vice Chair from this date.

Sir David has had a long career in healthcare management, predominantly in the NHS. He has held several CEO roles at several NHS trusts, including the Royal Free London NHS Foundation Trust, the Whittington Hospital NHS Trust and NHS Haringey Trust. During December 2021 and August 2023, he was the COO of NHS England, where he was responsible for overseeing all NHS operational delivery, including the response to the COVID-19 pandemic. Sir David is a non-executive director of AXA UK and Ireland, a board member of Health Data Research UK, a fellow of the Royal Society of Medicine, a senior fellow of the Institute for Healthcare Improvement and a trustee of the Royal College of Radiologists. As a result of Sir David’s appointment with AXA UK and Ireland, the Company does not consider him to be independent.

Jill Anderson will join as an independent Non-Executive Director and will chair Spire’s Audit and Risk Committee and be a member of the Remuneration Committee on appointment. Jill has 30 years’ experience in the healthcare sector, including executive responsibility in finance, commercial, research and supply chain functions across large multinational organisations principally with GSK plc. She is a trustee of Amref UK, an NGO focused on healthcare in Africa and was an associate non-executive director of London Ambulance Service until 2022.

Having completed over 10 years of service, Professor Dame Janet Husband will step down from the Board at the Company’s annual general meeting on 14 May 2025 and will not seek re-election by shareholders.

Sir David Sloman commented: “I am delighted to be joining the Board of Spire and look forward to working with Spire to deliver their Purpose of making a positive difference to people’s lives through outstanding personalised care.”

Jill Anderson said: “I am delighted and privileged to join Spire Healthcare‘s Board of Directors. It is a great time to be joining and I look forward to working with the team.”

Sir Ian Cheshire, Spire Healthcare’s Non-Executive Chairman, said: “We are delighted that both Jill and Sir David have agreed to join Spire’s Board. The breadth of their expertise and experience in healthcare will be a highly valuable addition to our Board and the Company. I look forward to welcoming Sir David as the new chair of the Clinical Governance and Safety Committee and Jill as the new chair of the Audit and Risk Committee.

 “I would also like to thank Dame Janet for her considerable contribution to Spire since the Company listed in 2014 and also Debbie White for chairing the Audit and Risk Committee on an interim basis.”

Justin Ash, Spire Healthcare CEO said: “I am pleased to welcome Jill and Sir David to the Spire Board. Jill’s extensive senior financial and commercial expertise, along with Sir David’s experience of operating at the highest levels within the NHS, brings direct and relevant skills to the Board, and will help guide Spire though the coming years. I would like to thank Dame Janet for her commitment to Spire over the past 10 years.”